32 | Chapter 1 18. Zorzi SF, Agostini G, Chu F, Tagliabue M, Pietrobon G, Corrao G, et al. Upfront transoral robotic surgery (TORS) versus intensity-modulated radiation therapy (IMRT) in HPV-positive oropharyngeal cancer: realworld data from a tertiary comprehensive cancer centre. Acta Otorhinolaryngol Ital. 2022 Aug;42(4):334–47. 19. de Veij Mestdagh PD, Schreuder WH, Vogel WV, Donswijk ML, van Werkhoven E, van der Wal JE, et al. Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial. BMC Cancer. 2019 Nov 14;19(1):1110. 20. Navran A, Heemsbergen W, Janssen T, Hamming-Vrieze O, Jonker M, Zuur C, et al. The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT). Radiother Oncol. 2019 Jan;130:25–31. 21. Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, et al. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol. 2022 Jan 10;40(2):138–49. 22. Strohl MP, Wai KC, Ha PK. De-intensification strategies in HPV-related oropharyngeal squamous cell carcinoma—a narrative review. Ann Transl Med. 2020 Dec;8(23):1601. 23. Meldgaard Justesen M, Kronberg Jakobsen K, Fenger Carlander AL, Hjordt Holm Larsen M, Wessel I, Kiss K, et al. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020. Oral Oncology. 2024 May 1;152:106783. 24. Laryngeal & Hypopharyngeal Cancer | Throat Cancer [Internet]. [cited 2024 Apr 30]. Available from: https:// www.cancer.org/cancer/types/laryngeal-and-hypopharyngeal-cancer.html 25. Mo HL, Li J, Yang X, Zhang F, Xiong JW, Yang ZL, et al. Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: a systematic review and meta-analysis. Lasers Med Sci. 2017 Feb;32(2):461–7. 26. Forastiere AA, Weber RS, Trotti A. Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes. J Clin Oncol. 2015 Oct 10;33(29):3262–8. 27. Bhat GR, Hyole RG, Li J. Head and neck cancer: Current challenges and future perspectives. Adv Cancer Res. 2021;152:67–102. 28. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017 Mar;67(2):93–9. 29. Putten L, Bree R, Doornaert PA, Buter J, Eerenstein SEJ, Rietveld DHF, et al. Salvage surgery in postchemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review. Acta Otorhinolaryngol Ital. 2015 Jun;35(3):162–72. 30. Hasan Z, Dwivedi RC, Gunaratne DA, Virk SA, Palme CE, Riffat F. Systematic review and meta-analysis of the complications of salvage total laryngectomy. European Journal of Surgical Oncology (EJSO). 2017 Jan 1;43(1):42–51. 31. Bozec A, Culié D, Poissonnet G, Dassonville O. Current Role of Total Laryngectomy in the Era of Organ Preservation. Cancers [Internet]. 2020 [cited 2024 Mar 22];12. Available from: https://consensus.app/papers/ role-total-laryngectomy-organ-preservation-bozec/17d7c2f8bc355c78afbedd6813109136/ 32. Grover S, Swisher-McClure S, Mitra N, Li J, Cohen R, Ahn P, et al. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes. International journal of radiation oncology, biology, physics. 2015;92 3:594–601. 33. Rodrigo J, López F, Llorente J, Álvarez-Marcos C, Suárez C. [Results of total laryngectomy as treatment for locally advanced laryngeal cancer in the organ-preservation era]. Acta otorrinolaringologica espanola. 2015;66 3:132-8. 34. Forastiere AA, Ismaila N, Lewin JS, Nathan CA, Adelstein DJ, Eisbruch A, et al. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018 Apr 10;36(11):1143–69.
RkJQdWJsaXNoZXIy MTk4NDMw